Attached files

file filename
8-K - FORM 8-K - HEALTHCARE TRUST OF AMERICA, INC.d255715d8k.htm

Exhibit 99.1

LOGO

PRESS RELEASE

Financial Contact:

Kellie S. Pruitt

Chief Financial Officer

Healthcare Trust of America, Inc.

480-998-3478

kelliepruitt@htareit.com

Healthcare Trust of America, Inc. Reports Third Quarter

2011 Results

Scottsdale, Arizona (November 14, 2011) – Healthcare Trust of America, Inc. (“HTA” or the “Company”), a fully integrated, self-administered, and self-managed real estate investment trust focused primarily on medical office buildings (“MOBs”), announced results for the third quarter ended September 30, 2011.

HTA’s third quarter financial results reflect the strength of HTA’s high quality medical office portfolio combined with the financial flexibility provided by its low leveraged balance sheet. For the third quarter of 2011, HTA’s normalized funds from operations, or normalized FFO, increased by 38% to $28.5 million from $20.6 million for the third quarter of 2010. Normalized FFO excludes from FFO acquisition-related expenses, transition-related charges, termination fee revenue and non-cash fair value adjustments for derivative financial instruments. Net income decreased to $234,000 in the third quarter of 2011 compared to $1.0 million in the third quarter of 2010, primarily because of a $589,000 non-cash loss on interest rate swaps in the third quarter of 2011 compared to a $774,000 non-cash gain in the third quarter of 2010, for a net difference of $1.4 million. Set forth below is a reconciliation of FFO and normalized FFO, non-GAAP measures, to net income (loss).

Normalized FFO increased by 45%, from $59.2 million for the nine months ended September 30, 2010 to $85.7 million for the nine months ended September 30, 2011. Net income also improved to $3.6 million for the nine months ended September 30, 2011 compared to $771,000 during the same period in the prior year, representing a 367% increase.

In October 2011, HTA completed the acquisition of two Class A MOBs located in Phoenix, Arizona, for $32 million, with 118,000 square feet of gross leasable area, or GLA, and a combined occupancy of 88%. At the end of the third quarter 2011, HTA entered into a purchase and sale agreement to acquire a 203,000 square foot on-campus MOB located in Novi, Michigan for $51.32 million with 98% occupancy. The closing of this acquisition is subject to a number of conditions.

As of September 30, 2011, 96% of HTA’s operating portfolio, based on GLA, is located on or adjacent to, or is anchored by, the campuses of nationally and regionally recognized healthcare systems. At the end of the third quarter 2011, HTA had a strong cash position with cash on hand of $122.3 million, an unused $575 million unsecured credit facility and a leverage ratio of mortgage and secured loans payable to total assets of 28%. In July 2011, HTA received an investment grade credit rating due to its MOB operating fundamentals and low-levered balance sheet position, improving HTA’s ability to access the debt markets and achieve favorable pricing.


Funds from Operations, Modified Funds from Operations and Normalized Funds from Operations

HTA defines FFO, a non-GAAP measure, as net income or loss computed in accordance with GAAP, excluding gains or losses from sales of property but including asset impairment write downs, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO. HTA uses modified funds from operations, or MFFO, which excludes from FFO transition charges and acquisition-related expenses, to further evaluate how its portfolio might perform after its acquisition stage is complete and the sustainability of its distributions in the future.

Normalized FFO is calculated by deducting from MFFO termination fee revenue and adjusting for gains/losses in the change in fair value of derivative financial instruments. Like MFFO, HTA believes that normalized FFO is a useful supplemental measure for evaluating the potential future performance of the portfolio without regard to non-routine items and non-cash fair value adjustments for derivative financial instruments.

FFO, MFFO, or normalized FFO should not be considered as an alternative to net income or to cash flows from operating activities and are not intended to be used as a liquidity measure indicative of cash flow available to fund HTA’s cash needs, including its ability to make distributions. FFO, MFFO and normalized FFO should be reviewed in connection with other GAAP measurements. For more information on FFO and MFFO, please see HTA’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 as filed with the Securities and Exchange Commission.

The following is the reconciliation of FFO, MFFO and normalized FFO to net income for the three months ended September 30, 2011 and 2010:

 

     Three Months Ended ,  
     September 30,
2011
     September 30,
2010
 

Net income

   $ 234,000       $ 1,008,000   

Depreciation and amortization — consolidated properties

     27,360,000         19,854,000   

Net (income) loss attributable to noncontrolling interest of limited partners

     (9,000)         125,000   

Depreciation and amortization related to noncontrolling interests

     (66,000)         (616,000)   
  

 

 

    

 

 

 

FFO attributable to controlling interest

   $ 27,519,000       $ 20,371,000   
  

 

 

    

 

 

 

FFO per share — basic and diluted

   $ 0.12       $ 0.12   
  

 

 

    

 

 

 

Acquisition-related expenses

     404,000         1,019,000   

Transition-related charges

             -   
  

 

 

    

 

 

 

MFFO attributable to controlling interest

   $ 27,923,000       $ 21,390,000   
  

 

 

    

 

 

 

MFFO per share — basic and diluted

   $ 0.12       $ 0.13   
  

 

 

    

 

 

 

Termination fee revenue

     -         -   

Net loss (gain) on change in fair value of derivative instruments

     589,000         (774,000)   
  

 

 

    

 

 

 

Normalized FFO attributable to controlling interest

   $ 28,512,000       $ 20,616,000   
  

 

 

    

 

 

 

Normalized FFO per share — basic and diluted

   $ 0.12       $ 0.12   
  

 

 

    

 

 

 

Weighted average common shares outstanding:

     

  Basic

     229,390,941         166,281,800   
  

 

 

    

 

 

 

  Diluted

     229,568,328         166,480,852   
  

 

 

    

 

 

 


The following is reconciliation of FFO, MFFO and normalized FFO to net income for the nine months ended September 30, 2011 and 2010:

 

     Nine months Ended September 30,  
     2011      2010  

Net income

   $ 3,586,000       $ 771,000   

Depreciation and amortization — consolidated properties

     80,811,000         55,767,000   

Net (income) loss attributable to noncontrolling interest of limited partners

     (40,000)         60,000   

Depreciation and amortization related to noncontrolling interests

     (193,000)         (667,000)   
  

 

 

    

 

 

 

FFO attributable to controlling interest

   $ 84,164,000       $ 55,931,000   
  

 

 

    

 

 

 

FFO per share — basic and diluted

   $ 0.38       $ 0.36   
  

 

 

    

 

 

 

Acquisition-related expenses

     1,827,000         6,845,000   

Transition-related charges

             1,006,000   
  

 

 

    

 

 

 

MFFO attributable to controlling interest

   $ 85,991,000       $ 63,782,000   
  

 

 

    

 

 

 

MFFO per share — basic and diluted

   $ 0.39       $ 0.41   
  

 

 

    

 

 

 

Termination fee revenue

     (1,417,000)         (8,000)   

Net loss (gain) on change in fair value of derivative instruments

     1,163,000         (4,571,000)   
  

 

 

    

 

 

 

Normalized FFO attributable to controlling interest

   $ 85,737,000       $ 59,203,000   
  

 

 

    

 

 

 

Normalized FFO per share — basic and diluted

   $ 0.38       $ 0.38   
  

 

 

    

 

 

 

Weighted average common shares outstanding:

     

  Basic

     224,151,270         155,480,689   
  

 

 

    

 

 

 

  Diluted

     224,328,657         155,679,741   
  

 

 

    

 

 

 

Net Operating Income

Net operating income, or NOI, is a non-GAAP financial measure that is defined as net income, computed in accordance with GAAP, generated from HTA’s total portfolio of properties before interest expense, general and administrative expenses, depreciation, amortization, certain one-time charges, and interest and dividend income. HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with management of the properties. Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance in the real estate community. However, HTA’s use of the term NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing this amount.

The following is the reconciliation of NOI to net income for the three and nine months ended September 30, 2011 and 2010:

 

     Three Months Ended September 30,      Nine months Ended September 30,  
     2011      2010      2011      2010  

Net income

   $ 234,000       $ 1,008,000       $ 3,586,000       $ 771,000   

Add:

           

General and administrative

     8,160,000         5,096,000         22,223,000         12,781,000   

Acquisition-related expenses

     404,000         1,019,000         1,827,000         6,845,000   

Depreciation and amortization

     27,360,000         19,854,000         80,811,000         55,767,000   

Interest expense and net loss on derivative financial instruments

     10,916,000         7,706,000         32,155,000         21,900,000   

Less:

           

Interest and dividend income

     (17,000)         (24,000)         (161,000)         (74,000)   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net operating income

   $ 47,057,000       $ 34,659,000       $ 140,441,000       $ 97,990,000   
  

 

 

    

 

 

    

 

 

    

 

 

 

Note that all figures are rounded to reflect approximate amounts. For more information on financial results, please see HTA’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 as filed with the Securities and Exchange Commission.

For more information on Healthcare Trust of America, Inc., please visit www.htareit.com.


About Healthcare Trust of America, Inc.

Healthcare Trust of America, Inc. is a fully integrated, self-administered, self-managed real estate investment trust. Since its formation in 2006, HTA has made 79 geographically diverse acquisitions valued at approximately $2.3 billion based on purchase price, which includes 244 buildings and two other real estate-related assets. HTA’s portfolio totals approximately 11.2 million square feet and includes 220 medical office buildings, ten hospitals, nine skilled nursing and assisted living facilities and five healthcare-related office buildings located in 25 states. With average occupancy of 91%, including leases signed but not commenced, over half of HTA’s current annualized base rent comes from credit rated tenants. Ninety-six percent of HTA’s portfolio is strategically located on-campus or aligned with recognized healthcare systems.

FORWARD-LOOKING LANGUAGE

This press release contains certain forward-looking statements with respect to HTA. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to, the following: we may not be able to access the public debt markets or access other sources of debt or equity financing, which may limit our growth; our results may be impacted by, among other things, uncertainties relating to the debt and equity capital markets; uncertainties relating to changes in general economic and real estate conditions; uncertainties relating to the implementation of recent healthcare legislation; uncertainties regarding changes in the healthcare industry; the uncertainties relating to the implementation of HTA’s real estate investment strategy; and other risk factors as outlined in HTA’s periodic reports, as filed with the Securities and Exchange Commission.

 


Healthcare Trust of America, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

As of September 30, 2011 and December 31, 2010

(Unaudited)

 

     September 30, 2011     December 31, 2010  
ASSETS     

Real estate investments, net

   $ 1,785,287,000      $ 1,797,463,000   

Real estate notes receivable, net

     58,850,000        57,091,000   

Cash and cash equivalents

     122,303,000        29,270,000   

Accounts and other receivables, net

     14,838,000        16,385,000   

Restricted cash and escrow deposits

     17,942,000        26,679,000   

Identified intangible assets, net

     279,294,000        304,355,000   

Other assets, net

     55,560,000        40,552,000   
  

 

 

   

 

 

 

Total assets

   $ 2,334,074,000      $ 2,271,795,000   
  

 

 

   

 

 

 
LIABILITIES AND EQUITY     

Liabilities:

    

Mortgage and secured term loans payable, net

   $ 650,111,000      $ 699,526,000   

Outstanding balance on unsecured revolving credit facility

     —          7,000,000   

Accounts payable and accrued liabilities

     48,425,000        43,033,000   

Derivative financial instruments—interest rate swaps

     2,104,000        1,527,000   

Security deposits, prepaid rent and other liabilities

     20,313,000        16,168,000   

Identified intangible liabilities, net

     12,198,000        13,428,000   
  

 

 

   

 

 

 

Total liabilities

     733,151,000        780,682,000   

Commitments and contingencies

    

Redeemable noncontrolling interest of limited partners

     3,784,000        3,867,000   

Stockholders’ Equity:

    

Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding

     —          —     

Common stock, $0.01 par value; 1,000,000,000 shares authorized; 227,611,070 and 202,643,705 shares issued and outstanding as of September 30, 2011 and December 31, 2010, respectively

     2,278,000        2,026,000   

Additional paid-in capital

     2,022,398,000        1,795,413,000   

Accumulated deficit

     (427,537,000     (310,193,000
  

 

 

   

 

 

 

Total stockholders’ equity

     1,597,139,000        1,487,246,000   
  

 

 

   

 

 

 

Total liabilities and equity

   $ 2,334,074,000      $ 2,271,795,000   
  

 

 

   

 

 

 

 


Healthcare Trust of America, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Nine Months Ended September 30, 2011 and 2010

(Unaudited)

 

     Three Months Ended September 30,     Nine Months Ended September 30,  
     2011     2010     2011     2010  

Revenues:

        

  Rental income

   $ 68,291,000      $ 50,847,000      $ 203,960,000      $ 139,640,000   

  Interest income from mortgage notes receivable and other income

     1,649,000        1,649,000        4,946,000        5,937,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

    Total revenues

     69,940,000        52,496,000        208,906,000        145,577,000   

Expenses:

        

  Rental expenses

     22,883,000        17,837,000        68,465,000        47,587,000   

  General and administrative

     8,160,000        5,096,000        22,223,000        12,781,000   

  Acquisition-related expenses

     404,000        1,019,000        1,827,000        6,845,000   

  Depreciation and amortization

     27,360,000        19,854,000        80,811,000        55,767,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

    Total expenses

     58,807,000        43,806,000        173,326,000        122,980,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before other income (expense)

     11,133,000        8,690,000        35,580,000        22,597,000   

Other income (expense):

        

  Interest expense (including amortization of deferred financing costs and debt premium/discount):

        

    Interest expense related to mortgage loan payables and credit facility

     (9,936,000     (6,183,000     (29,875,000     (18,581,000

    Interest expense related to derivative financial instruments and net change in fair value of derivative financial instruments

     (980,000     (1,523,000     (2,280,000     (3,319,000

  Interest and dividend income

     17,000        24,000        161,000        74,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

     234,000        1,008,000        3,586,000        771,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

  Less: Net (income) loss attributable to noncontrolling interest of limited partners

     (9,000     125,000        (40,000     60,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to controlling interest

   $ 225,000      $ 1,133,000      $ 3,546,000      $ 831,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share attributable to controlling interest on distributed and undistributed earnings — basic and diluted

   $ 0.00      $ 0.01      $ 0.02      $ 0.01   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding —

        

  Basic

     229,390,941        166,281,800        224,151,270        155,480,689   
  

 

 

   

 

 

   

 

 

   

 

 

 

  Diluted

     229,568,328        166,480,852        224,328,657        155,679,741